For summer season, Croatia will dispense ePrescriptions for Finnish citizens and allow the access of Czech patient summaries, while Croatians travelling Estonia can get their ePrescriptions dispensed there. These exchanges will now be possible as the eHealth Network, comprising e-health agencies in Europe, agreed on 2 April 2019 that

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a pharmacy in Estonia and retrieve medicine prescribed electronically by their doctor in Finland.

Patients in Europe are being let down by a global health innovation system which fails to deliver the treatments they need at prices that government can afford, according to a new report led by Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment.

A pilot study coordinated by researchers from FhP-AICOS (Fraunhofer Portugal AICOS) is encouraging healthcare shift workers to become aware of their physical activity and sleep rhythms, and to reflect about their work and lifestyle, using technology. Clockwork, a tech solution created to achieve this, is already being tested in Portugal at CUF hospitals, and it will get its debut in Hungary soon.

An initiative has been launched to ensure private healthcare data is recorded in the same way as NHS data in England, with the aim of improving consistency across the system. The Acute Data Alignment Programme (ADAPt) aims to integrate data on privately funded healthcare into NHS systems and standards for the first time.

The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola).

AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential applications of AI in healthcare, and the ethical issues arising from its use, in a new briefing note, Artificial Intelligence (AI) in healthcare and research, published today.